Literature DB >> 21165353

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Sanjay Mehta1, Doug Helmersen, Steeve Provencher, Naushad Hirani, Fraser D Rubens, Marc De Perrot, Mark Blostein, Kim Boutet, George Chandy, Carole Dennie, John Granton, Paul Hernandez, Andrew M Hirsch, Karen Laframboise, Robert D Levy, Dale Lien, Simon Martel, Gerard Shoemaker, John Swiston, Justin Weinkauf.   

Abstract

BACKGROUND: Pulmonary embolism is a common condition. Some patients subsequently develop chronic thromboembolic pulmonary hypertension (CTEPH). Many care gaps exist in the diagnosis and management of CTEPH patients including lack of awareness, incomplete diagnostic assessment, and inconsistent use of surgical and medical therapies.
METHODS: A representative interdisciplinary panel of medical experts undertook a formal clinical practice guideline development process. A total of 20 key clinical issues were defined according to the patient population, intervention, comparator, outcome (PICO) approach. The panel performed an evidence-based, systematic, literature review, assessed and graded the relevant evidence, and made 26 recommendations.
RESULTS: Asymptomatic patients postpulmonary embolism should not be screened for CTEPH. In patients with pulmonary hypertension, the possibility of CTEPH should be routinely evaluated with initial ventilation/perfusion lung scanning, not computed tomography angiography. Pulmonary endarterectomy surgery is the treatment of choice in patients with surgically accessible CTEPH, and may also be effective in CTEPH patients with disease in more 'distal' pulmonary arteries. The anatomical extent of CTEPH for surgical pulmonary endarterectomy is best assessed by contrast pulmonary angiography, although positive computed tomography angiography may be acceptable. Novel medications indicated for the treatment of pulmonary hypertension may be effective for selected CTEPH patients.
CONCLUSIONS: The present guideline requires formal dissemination to relevant target user groups, the development of tools for implementation into routine clinical practice and formal evaluation of the impact of the guideline on the quality of care of CTEPH patients. Moreover, the guideline will be updated periodically to reflect new evidence or clinical approaches.

Entities:  

Mesh:

Year:  2010        PMID: 21165353      PMCID: PMC3006154          DOI: 10.1155/2010/704258

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  176 in total

Review 1.  Chronic thromboembolic pulmonary hypertension.

Authors:  P F Fedullo; W R Auger; K M Kerr; L J Rubin
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography.

Authors:  S Krüger; P Haage; R Hoffmann; C Breuer; A Bücker; P Hanrath; R W Günther
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

3.  Prognostic factors in medically treated patients with chronic pulmonary embolism.

Authors:  J Lewczuk; P Piszko; J Jagas; A Porada; S Wójciak; B Sobkowicz; K Wrabec
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

4.  Long-term treatment of pulmonary hypertension with aerosolized iloprost.

Authors:  S Machherndl; M Kneussl; H Baumgartner; B Schneider; V Petkov; P Schenk; I M Lang
Journal:  Eur Respir J       Date:  2001-01       Impact factor: 16.671

5.  Thrombophilic factors in chronic thromboembolic pulmonary hypertension.

Authors:  C C Colorio; M E Martinuzzo; R R Forastiero; G Pombo; Y Adamczuk; L O Carreras
Journal:  Blood Coagul Fibrinolysis       Date:  2001-09       Impact factor: 1.276

6.  Primary pulmonary artery sarcoma resembling chronic thromboembolic pulmonary disease.

Authors:  E J Kaplinsky; R R Favaloro; G Pombo; S V Perrone; C A Vigliano; J L Schnidt; R P Boughen
Journal:  Eur Respir J       Date:  2000-12       Impact factor: 16.671

7.  Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.

Authors:  J A Feinstein; S Z Goldhaber; J E Lock; S M Ferndandes; M J Landzberg
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

8.  Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension.

Authors:  T Iwase; N Nagaya; M Ando; T Satoh; F Sakamaki; S Kyotani; H Takaki; Y Goto; Y Ohkita; M Uematsu; N Nakanishi; K Miyatake
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

9.  Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes.

Authors:  A M D'Armini; B Cattadori; C Monterosso; C Klersy; V Emmi; F Piovella; G Minzioni; M Viganò
Journal:  Eur J Cardiothorac Surg       Date:  2000-12       Impact factor: 4.191

10.  Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

Authors:  M D Cappellini; L Robbiolo; B M Bottasso; R Coppola; G Fiorelli; A P Mannucci
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

View more
  12 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Pulmonary hypertension: diagnostic approach and optimal management.

Authors:  Nathan Hambly; Fahad Alawfi; Sanjay Mehta
Journal:  CMAJ       Date:  2016-05-02       Impact factor: 8.262

Review 4.  Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

Authors:  Ping Yu Xiong; Francois Potus; Winnie Chan; Stephen L Archer
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

5.  Mortality in US veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors.

Authors:  Aaron W Trammell; Amit J Shah; Lawrence S Phillips; C Michael Hart
Journal:  Pulm Circ       Date:  2019 Jan-Mar       Impact factor: 3.017

Review 6.  The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism.

Authors:  Halil Doğan; Albert de Roos; Jacob Geleijins; Menno V Huisman; Lucia J M Kroft
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

7.  Long-term prognosis and related factors towards patients with acute pulmonary thromboembolism.

Authors:  Xiaowei Gong; Zheng Duan; Yadong Yuan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Advanced imaging tools rather than hemodynamics should be the primary approach for diagnosing, following, and managing pulmonary arterial hypertension.

Authors:  Mario Gerges; Christian Gerges; Irene M Lang
Journal:  Can J Cardiol       Date:  2015-01-28       Impact factor: 5.223

9.  Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.

Authors:  Bernd Schweikert; David Pittrow; Carmine Dario Vizza; Joanna Pepke-Zaba; Marius M Hoeper; Anja Gabriel; Jenny Berg; Mirko Sikirica
Journal:  BMC Health Serv Res       Date:  2014-06-09       Impact factor: 2.655

10.  An improved technique for pulmonary endarterectomy.

Authors:  Ali Azari; Zahra Moravvej; Sara Afshar; Leila Bigdelu
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.